OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING For the Life Sciences Industry September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV Register at DecisionResourcesGroup.com/Events
DEAR COLLEAGUE, Cancer affects us all. Some reading this have survived it. Many have watched loved ones successfully battle through it, while others have felt the pain when a family member succumbs. We have had to deal with providers, hospital systems, caregivers, outpatient facilities, various treatments, plus figuring out how to pay for it all at a time when it feels like the weight of the world is on our family s shoulders. We are making progress: Industry is launching revolutionary medicines, many cancers are being diagnosed earlier, genomics are allowing us to pinpoint precise treatments, and survival rates are increasing. But when you view cancer from the patient s and family s perspective, you can see we still have a long way to go. With this in mind, we designed the Oncology Account Management Training Program. In this evolving treatment landscape, the business of cancer care has become increasingly complicated for industry and patients alike. New classes of treatments bring hope, but also logistical challenges ones that are made even more complex by a post-reform environment in which old models of care are being replaced. To help demystify it all, we bring together key players to share their perspectives on today s oncology landscape. They will discuss how we can work together to navigate this world and, as a result, help ease the process for patients and their families. Our faculty is truly outstanding! The agenda allows opportunities to engage with your customers, work with your peers, and participate in thought-provoking discussions throughout the 2.5-day event. Attendance is limited so please register early. Yours in training, Tony Pinsonault Vice President, Market Access DRG, PROGRAM FACULTY Jeffrey Patton, MD Lalan Wilfong, MD Vice President, Business Development PharmMedQuest Senior Director, Market Access Knowledge, Chief Executive Officer Tennessee Oncology Medical Director, Quality Programs and Value-Based Reimbursement Texas Oncology Barbara McAneny, MD Jayson Slotnik, JD, MPH Gordon Kuntz Bruce Feinberg, DO Managing Partner and Chief Executive Officer New Mexico Cancer Center Medical Director and Chief Executive Officer Innovative Oncology Business Solutions Partner Health Policy Strategies, Inc Senior Director of Strategy Via Oncology Vice President and Chief Medical Officer Cardinal Health Specialty Solutions Michael Kolodziej, MD Sheila Arquette, RPh Cheryl Larson Jerry Conway National Medical Director, Managed Care Strategy Independent Health Vice President Midwest Business Group on Health Vice President, Payer Relations and Reimbursement Foundation Medicine, Inc Atheer A Kaddis, PharmD Executive Vice President, Sales and Strategic Alignment Diplomat Specialty Pharmacy Ray Bailey, RPh Florida Cancer Specialists Michael Zeglinski, RPh Senior Vice President, Specialty Pharmacy OptumRx/BriovaRx Brad Hirsch, MD Senior Medical Director Medical Oncologist Texas Oncology
PROGRAM FALL 2016 TUESDAY SEPTEMBER 20 7:45 AM 8:30 AM Breakfast 8:30 AM 8:45 AM Opening Remarks Program Co-Chairs 8:45 AM 9:45 AM Oncology Overview 9:45 AM 10:00 AM Break Stakeholder perspectives from key influencers Drug management landscape: Opportunities and barriers Tactical opportunities today and what the future may hold 10:00 AM 11:30 AM Oncology Panel Session 11:30 AM 11:45 AM Break Jeffrey Patton, MD Chief Executive Officer Tennessee Oncology Lalan Wilfong, MD Medical Director, Quality Programs and Value-Based Reimbursement Texas Oncology Barbara McAneny, MD Managing Partner and Chief Executive Officer New Mexico Cancer Center Medical Director and Chief Executive Officer Innovative Oncology Business Solutions Payer (CMS/commercial) initiatives, implications on access to high-quality patient care, and oncology practice survival Impact of biosimilars and genomics on prescribing behavior Clinical pathways: Pros and cons Drug manufacturers role in the midst of evolving market dynamics 11:45 AM 1:00 PM The CMS Oncology Care Model 1:00 PM 2:00 PM Lunch Lalan Wilfong, MD Medical Director, Quality Programs and Value-Based Reimbursements Texas Oncology How this model aims to coordinate care at a lower cost to Medicare and to improve the patient experience and quality of care Tracking performance and utilizing quality metrics to provide constant feedback and performance-based payments Spillover to public payer/practice payment models Role of the Life Sciences Manufacturer 2:15 PM 3:15 PM Legislative Update: How National Policies Are Affecting Cancer Care 3:15 PM 3:30 PM Break Jayson Slotnik, JD, MPH Partner Health Policy Strategies, Inc Overview of the landscape and authorities Update on latest regulatory and legislative issues affecting access to cancer care Which stakeholders are affected and what they are doing about it 3:30 PM 5:00 PM Oncology Clinical Pathways Gordon Kuntz Senior Director of Strategy Via Oncology Bruce Feinberg, DO Vice President and Chief Medical Officer Cardinal Health Specialty Solutions Describe the various types of pathways programs Discuss the goals of a physician-facing pathways program Identify which elements of cancer care can be turned into pathways Explain how pathways are developed and maintained Use the decision support software as a delivery and measurement tool 5:00 PM 7:00 PM Networking Reception
WEDNESDAY SEPTEMBER 21 7:45 AM 8:30 AM Breakfast 8:45 AM 9:00 AM Day 1 Review 9:00 AM 10:00 AM Value-Based Payer Programs in Oncology 10:00 AM 10:15 AM Break Michael Kolodziej, MD Managed Care Strategy Acceptable alternatives to fee-for-service The oncology medical home Bundled payments How to address site of service Quality care measures 10:15 AM 12:15 PM Perspective From Regional/ National Payers and Employers 12:15 PM 1:15 PM Lunch Sheila Arquette, RPh Independent Health Michael Kolodziej, MD Managed Care Strategy Cheryl Larson Vice President Midwest Business Group on Health Describe the current trends and challenges in oncology drug management Explain the role of specialty pharmacy in maximizing patient therapeutic outcomes Communicate the value of designing a highperforming center-of-excellence based specialty pharmacy network Discuss new product information with payers Distinguish between what is valuable to a payer and what is not Explain the coverage requirements to providers 1:15 PM 2:30 PM Precision Medicine: How Genomically Matched Treatment Is Transforming Cancer Care 2:30 PM 2:45 PM Break Jerry Conway Vice President, Payer Relations and Reimbursement Foundation Medicine, Inc Explore how precision medicine is poised to affect commercial strategy Learn critical managed care strategies, tactics, and tools Discuss how to achieve value-based market access as precision medicine evolves 2:45 PM 4:15 PM Payers, Providers, IDNs, GPOs, and the Role of Specialty Pharmacy: How the Life Sciences Industry Can Best Navigate Its Customer Base THURSDAY SEPTEMBER 22 7:45 AM 8:30 AM Breakfast Atheer A Kaddis, PharmD Executive Vice President, Sales and Strategic Alignment Diplomat Specialty Pharmacy 6:45 AM 7:45 AM Day 2 Review 8:00 AM 9:30 AM Specialty Pharmacy Models for Oncology Atheer A Kaddis, PharmD Executive Vice President, Sales and Strategic Alignment Diplomat Specialty Pharmacy Sheila Arquette, RPh Independent Health Ray Bailey, RPh Florida Cancer Specialists Michael Zeglinski, RPh Senior Vice President, Specialty Pharmacy OptumRx/BriovaRx Physician office dispensing Independent specialty pharmacy Payer/PBM/specialty pharmacy model 9:30 AM 9:45 AM Break 9:45 AM 11:00 AM How Data and Analytics Are Changing Cancer Care Brad Hirsch, MD Senior Medical Director, Medical Oncologist, Texas Oncology 11:00 AM Box Lunch Pickup List the functions of a specialty pharmacy within the oncology marketplace Describe the current competitive landscape regarding the specialty pharmacy industry, focusing on oncology Identify the needs of various stakeholders in regards to oncology pharmaceuticals Demonstrate the ability to collaborate with stakeholders Implement strategies to successfully navigate the complexities of oncology pharmaceuticals Current data gaps and connecting data from disparate stakeholders to create actionable clinical insights Connectivity between academic hospitals and communitybased oncology practices How Flatiron is using data to support Life Sciences Manufacturer research and development
REGISTRATION OAMT is a comprehensive, hands-on training program designed to provide the Life Sciences Industry with the knowledge, techniques, and confidence to successfully work with their oncology customers. INDIVIDUAL REGISTRATION Fee: $3,795 Your registration fee includes: Breakfast, lunch, and refreshments daily Evening networking reception About The ARIA Resort Described as the crown jewel of the 67-acre CityCenter urban metropolis, ARIA Resort & Casino boasts an illustrious list of firsts for the Las Vegas Strip and beyond: It s not only the largest hotel in the world to earn the Leadership in Energy and Environmental Design s Gold certification from the US Green Building Council, but it also features the most technologically advanced guest rooms in the country. Registration information: All payments must be received prior to the program All cancellations are subject to a $200 cancellation fee No refunds will be granted after September 9, 2016 Cancelled registrations and/or no-shows will not be carried over to future programs LOCATION AND ACCOMMODATION ARIA Resort & Casino 3730 S Las Vegas Blvd Las Vegas, NV 89158 866-359-7757 We are pleased to offer a discounted room rate of $166 per night for OAMT attendees. Reserve your room by Monday, August 29, to take advantage of this reduced rate. Reserve your hotel room online at DecisionResourcesGroup.com/Events.
OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING For the Life Sciences Industry 5 Wood Hollow Road Parsippany, NJ 07054 is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. DecisionResourcesGroup.com